{
  "id": 16098689,
  "title": "OpenAI Ran Nearly 2,000 AI Agents on Brain Data: What They Found in 32 Minutes",
  "url": "https://urgent.news/2026/10/22/openai-ran-nearly-2-000-ai-agents-on-brain-data-what-they-found-in-32",
  "topic": "ai",
  "section": "AI",
  "published": "2026-10-22T17:09:21.000Z",
  "source": {
    "name": "TechRepublic",
    "slug": "techrepublic",
    "url": "https://www.techrepublic.com/article/news-openai-ai-agents-brain-research/"
  },
  "original_language": "en",
  "account": "OpenAI utilized nearly 2,000 AI agents to scrutinize mouse brain-cell data within a 32-minute timeframe, revealing potential connections to neurological ailments for future exploration. In collaboration with PerturbAI and Scripps Research, OpenAI deployed the AI agents to dissect data from seven and a half million mouse brain-cell nuclei, identifying possible links to neurological diseases. The research team employed CRISPR gene-editing technology to disrupt 1,947 disease-associated genes, enabling the AI agents to examine the cellular responses. The analysis was conducted using GPT-Rosalind, with each agent focusing on a single gene disruption. The findings were compiled into a searchable database, linking genetic changes to their corresponding effects and published research articles. The multi-agent approach generated over 700 scientific references, compared to 11 references in a single-agent analysis. Upon expert evaluation, the multi-agent interpretations were preferred 75% of the time, although this did not confirm the validity of the proposed disease mechanisms. The study underscores the potential of AI in accelerating the analysis of complex biological datasets, but it also highlights the necessity of laboratory validation for laboratory-tested hypotheses. OpenAI estimates that manual review could take months or even a year, making the AI-assisted approach a significant time-saver. The findings offer potential leads for AI-assisted drug discovery, potentially benefiting research organizations working with Perry syndrome or tuberous sclerosis. However, the rapid generation of AI-generated hypotheses does not guarantee their laboratory validation, and the ultimate impact on medical breakthroughs remains uncertain.",
  "summary": "OpenAI used nearly 2,000 AI agents to analyze mouse brain-cell data in 32 minutes, uncovering possible links to neurological diseases for further study. The post OpenAI Ran Nearly 2,000 AI Agents on Brain Data: What They Found in 32 Minutes appeared first on TechRepublic .",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}